日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Complement-Mediated Kidney Diseases: Role of Alternative Pathway in Glomerular Inflammation

补体介导的肾脏疾病:替代途径在肾小球炎症中的作用

Barratt, Jonathan; Garred, Peter; Lafayette, Richard A; Zhang, Hong; Floege, Jürgen

Loss of flavonol 3-O-glucosyltransferase activity confers soybean resistance to leaf-chewing insects

黄酮醇3-O-葡萄糖基转移酶活性的丧失赋予大豆对食叶害虫的抗性

Prabhakar, P K; Ortega, M A; Ha, B-K; LaFayette, P R; Harding, S A; Tsai, C J; Urbanowicz, B R; Boerma, H R; Parrott, W A

Silver-Doped Diamond-Like Carbon Coatings on Ti(6)Al(4)V Alloy with Enhanced Antibacterial and Cytocompatible Properties

银掺杂类金刚石碳涂层在Ti(6)Al(4)V合金上的应用及其增强的抗菌和细胞相容性性能

Reim Del' Gaudio Pignataro, Rossana; Vegian, Mariana; Silva, Diego Morais; Pereira, André Luis de Jesus; Soares da Silva Sobrinho, Argemiro; Souto Lepesqueur, Laura Soares; Koga-Ito, Cristiane Yumi; Nogueira Júnior, Lafayette

Regional Variation in Transplant Utilization and Agonal Times among Donation after Circulatory Death Lung Donors in the United States

美国循环死亡后肺捐献者移植利用率和濒死时间的区域差异

Noda, Kentaro; Coster, Jenalee N; Zhang, Kunning; Lafayette, Alison; Furukawa, Masashi; Sanchez, Pablo G

Health Care Resource Utilization and Productivity Impairment in Adults with Immunoglobulin A Nephropathy: A Real-World, Observational, Global Analysis

免疫球蛋白A肾病成人患者的医疗资源利用和生产力受损情况:一项真实世界、观察性、全球性分析

Tang, Sydney C W; Roccatello, Dario; Aldworth, Carolina; Ndife, Briana; Mallik, Suparna; George, Aneesh Thomas; Kattlun, Julia; Pletscher, Mark; Hirst, Ceri; Kroes, Michel Anton; Garratt-Wheeldon, Jade; Chatterton, Emma; de Courcy, Jonathan; Lafayette, Richard A

Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial

Ravulizumab治疗IgA肾病的疗效和安全性:一项II期随机双盲安慰剂对照试验

Lafayette, Richard; Tumlin, James; Fenoglio, Roberta; Kaufeld, Jessica; Pérez Valdivia, Miguel Ángel; Wu, Mai-Szu; Susan Huang, Shih-Han; Alamartine, Eric; Kim, Sung Gyun; Yee, Min; Kateifides, Andreas; Rice, Kara; Garlo, Katherine; Barratt, Jonathan

Safety and Efficacy of Avacopan in Patients with Complement 3 Glomerulopathy: Randomized, Double-Blind Clinical Trial

阿伐可泮治疗补体3肾小球病患者的安全性和有效性:随机、双盲临床试验

Bomback, Andrew S; Herlitz, Leal C; Kedia, Priyanka Punit; Petersen, Jeffrey; Yue, Huibin; Lafayette, Richard A

Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy

阿他西普治疗IgA肾病的开放标签扩展研究的长期结果

Barratt, Jonathan; Barbour, Sean J; Brenner, Robert M; Cooper, Kerry; Wei, Xuelian; Eren, Necmi; Floege, Jürgen; Jha, Vivekanand; Kim, Sung Gyun; Maes, Bart; Phoon, Richard K S; Singh, Harmeet; Tesař, Vladimír; Lafayette, Richard

Authors' Reply: Complement Inhibition Therapy in IgA Nephropathy: Total or Selective Inhibition?

作者回复:IgA肾病中的补体抑制疗法:完全抑制还是选择性抑制?

Barratt, Jonathan; Garlo, Katherine; Kateifides, Andreas; Lafayette, Richard

Authors' Reply: Ravulizumab in IgA Nephropathy: A Promising Step Toward Disease Modification?

作者回复:Ravulizumab治疗IgA肾病:疾病改善方面有希望的一步?

Barratt, Jonathan; Farag, Youssef M K; Yee, Min; Lafayette, Richard